256例慢性肾脏病非透析患者的高敏肌钙蛋白I影响因素回顾性分析

摘要
图/表
参考文献
相关文章 (1)

全文:PDF(1861 KB)HTML(1 KB)
输出:BibTeX|EndNote(RIS)

摘要目的:探讨慢性肾脏病（chronic kidney disease,CKD）非透析患者高敏肌钙蛋白I（hypersensitive troponin I,hs-cTn I）水平的相关影响因素,为早期筛选、识别慢性肾脏病患者中的心血管事件危险人群提供帮助。方法:单中心回顾性分析解放军某医院2018年01月—2019 年01月期间住院诊断为CKD的非透析患者256例,将患者以hs-cTnI浓度0.034 ng/mL为界限分为hs-cTnI正常组（n=183）和hs-cTnI升高组（n=73）,比较两组患者一般资料及实验室指标[血肌酐（Scr）、心肌酶、血尿素氮（BUN）、同型半胱氨酸、β2微球蛋白、高敏C反应蛋白、甲状旁腺素（PTH）、hs-cTn I],每位患者都进行心脏彩超检查,分析患者的hs-cTn I相关影响因素。结果:两组患者冠心病病史、收缩压、肾小球滤过率（eGRF）、Scr、BUN、β2微球蛋白、PTH、血磷（P）、血红蛋白（Hb）、左心室质量指数（LVMI）、N-末端脑钠肽前体（NT- proBNP）比较差异具有统计学意义;多元线性逐步回归分析结果显示冠心病病史、Hb、NT-proBNP、LVMI、P 及PTH为hs-cTn I的影响因素,CKD 非透析患者的冠心病病史,Hb降低,P、PTH、NT-pro BNP和LVMI的升高可引起 hs-cTn I水平升高。结论:非透析CKD患者的冠心病病史、贫血、NT-proBNP 升高、左室肥大、甲状旁腺亢进及高磷血症会引起hs-cTn I升高。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	刘思言
	王湘川

关键词：慢性肾脏病,高敏肌钙蛋白I,心血管风险

Abstract：ObjectiveTo explore the related influencing factors of hs-cTnI level in non-dialysis patients with chronic kidney disease, and to provide help for early screening and identifiCation of Cardiovascular event risk groups in patients with chronic kidney disease.MethodsA single-center retrospective analysis was performed on 256 non-dialysis patients diagnosed with CKD who were hospitalized in a certain hospital of the People's Liberation Army from January 2018 to January 2019. Patients were divided into normal hs-cTnI group (n=183) and elevated hs-cTnI group (n=73) with hs-cTnI concentration of 0.034 ng/mL. General data and laboratory indicators (serum creatinine, myocardial enzyme, blood urea nitrogen, homocysteine, β2 microglobulin, hypersensitive C-reactive protein, parathyroid hormone, hs-cTnI) were compared between the two groups. Color Doppler ultrasound was performed for each patient, and relevant statistical methods were used to analyze the affecting factors of hs-cTnI in the patients.ResultsThere were statistically significant differences in coronary heart disease history, systolic blood pressure, eGRF, Scr, BUN, β2 microglobulin, PTH, P, hemoglobin (Hb), left ventricular mass index (LVMI) and N terminal-pro brain natriuretic peptide (NT-proBNP) between the two groups. The results of multiple linear stepwise regression analysis showed that coronary heart disease history, Hb, NT-proBNP, LVMI, P and PTH were the influencing factors of hs-cTnI. The coronary heart disease history of non-dialysis patients with CKD showed a decrease in Hb. The increase of P, PTH, NT-pro BNP and LVMI Can lead to the increase of hs-cTn I level.ConclusionA history of coronary heart disease, anemia, elevated NT-proBNP, left ventricular hypertrophy, hyperparathyroidism, and hyperphosphatemia in non-dialysis CKD patients can cause hypersensitive troponin I to increase.

Key words：chronic kidney disease hypersensitive troponin I cardiovascular event

收稿日期:2023-03-29

中图分类号:

R692.5

通讯作者:王湘川,E-mail：634263633@qq.com

引用本文:

刘思言, 王湘川. 256例慢性肾脏病非透析患者的高敏肌钙蛋白I影响因素回顾性分析[J]. 金宝搏官方188学报(医学版), 2023, 20(4): 120-123. LIU Siyan, WANG Xiangchuan. Retrospective analysis of the influential factors of hypersensitive troponin I in 256 non-dialysis patients with chronic kidney disease. HuNan ShiFan DaXue XueBao(YiXueBan), 2023, 20(4): 120-123.

链接本文:

http://yxb.hunnu.edu.cn/CN/或http://yxb.hunnu.edu.cn/CN/Y2023/V20/I4/120

[1] deFilippi C, Seliger SL, Kelley W, et al. Interpreting Cardiac troponin results from high-sensitivity assays in chronic kidney disease without acute coronary syndrome[J]. Clin Chem, 2012, 58(9): 1342-1351.
[2] Astor BC, Hallan SI, Miller ER, et al.Glomerular filtration rate, albuminuria, and risk of Cardiovascular and all-Cause mortality in the US population[J]. Am J Epidemiol, 2008, 167(10): 1226-1234.
[3] Thygesen K, Alpert JS, Jaffe AS, et al.Third Universal Definition of Myocardial Infarction[J]. Circulation, 2012, 126(16): 2020-2035.
[4] 杨涛, 张永军, 郑亮, 等. 心电图新标准对高血压合并超重和肥胖人群左心室肥厚的诊断效能研究[J]. 中国全科医学, 2022, 25(36): 4502-4508.
[5] Yang CW, Li H, Thomas L, et al.Retrospective Cause analysis of troponin I elevation in non-Ca D patients[J]. Medicine, 2017, 96(37): e8027.
[6] 杨超, 王晋伟, 杨尧政, 等. 贫血及慢性肾脏病对糖尿病人群心脑血管事件发生与死亡的影响[J]. 北京大学学报 (医学版), 2018, 50(3): 495-500.
[7] 赵新菊. 慢性肾脏病贫血与左心室肥厚[J]. 中国血液净化, 2018, 17(7): 438-441.
[8] Schmid H, Schiffl H, Lederer SR.Erythropoiesis-stimulating agents, hypertension and left ventricular hypertrophy in the chronic kidney diseasepatient[J]. Curr Opin Nephrol Hypertens, 2011, 20(5): 465-470.
[9] Defilippi CR, Fink JC, Nass CM, et al.N-terminal pro-B-type natriuretic peptide for predicting coronary disease and left ventricular hypertrophy in asymptomatic CKD not requiring dialysis[J]. Am J Kidney Dis, 2005, 46(1): 35-44.
[10] 丁雪梅. 心肌肌钙蛋白及N-末端脑钠肽前体水平在老年慢性肾脏病中的变化及与预后的相关性[J]. 中国老年学杂志, 2014, 34(12): 3314-3316.
[11] NT-proBNP 临床应用中国专家共识小组. NT-proBNP 临床应用中国专家共识[J]. 中国心血管病研究, 2011, 9(6): 401-408.
[12] 耿旭, 马宾. BNP及NT-proBNP和心肌缺血缺氧关系的研究进展[J]. 医学综述, 2014, 20(8): 1374-1376.
[13] 王金艳, 吴国庆, 章念伟, 等. 早中期慢性肾脏病患者血清FGF-23水平与左心室肥厚关系的研究[J]. 江西医药, 2021, 56(8): 1125-1128.
[14] 谭若芸, 王笑云. 尿毒症毒素与心血管病变[J]. 中国血液净化, 2004, 3(2): 104-106.
[15] 杜春荔, 杨秉潜, 何春戈, 等. 终末期肾病患者甲状旁腺激素与肌钙蛋白水平的相关性研究[J]. 海南医学, 2016, 27(4): 534-536.